New evidence for the cardiovascular benefits of long chain omega-3 fatty acids

被引：21

作者：

Hansen S.N. ^{[1
]}

Harris W.S. ^{[1
]}

机构：

[1] Nutrition and Metabolic Disease Research Institute, Sanford Research/University of South Dakota, Sioux Falls, SD 57105

来源：

Current Atherosclerosis Reports | 2007年 / 9卷 / 6期

关键词：

Dioxin; Methyl Mercury; Coronary Heart Disease Risk; Coronary Heart Disease Event; Coronary Heart Disease Death;

D O I：

10.1007/s11883-007-0058-8

中图分类号：

学科分类号：

摘要：

The role of long chain omega-3 fatty acids (LC n-3 FAs) as cardioprotective agents has become even clearer with the recent publication of the Japan EPA Lipid Intervention Study. This was the largest randomized controlled trial in the field, and it demonstrated that even in a population with one of the highest LC n-3 FA intakes in the world, the addition of eicosapentaenoic acid could reduce cardiac events. A comprehensive analysis of the risks and benefits of fish consumption was likewise recently published that should quiet any remaining fears that there are substantial risks to consuming oily fish such as salmon. A new meta-analysis has now demonstrated that reduced tissue/blood levels of LC n-3 FAs provide a better indication of increased cardiovascular risk than the n-6:n-3 ratio. Finally, a supplementation study in cardiac surgery patients has demonstrated both the time course and extent of incorporation of LC n-3 FAs into the human heart. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：434 / 440

页数：6

共 25 条

[1]

Robinson J.G., Stone N.J., Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids, Am J Cardiol, 98, (2006)

[2]

Reiffel J.A., McDonald A., Antiarrhythmic effects of omega-3 fatty acids, Am J Cardiol, 98, (2006)

[3]

Jacobson T.A., Secondary prevention of coronary artery disease with omega-3 fatty acids, Am J Cardiol, 98, (2006)

[4]

Harris W.S., Bulchandani D., Why do omega-3 fatty acids lower serum triglycerides?, Curr Opin Lipidol, 17, pp. 387-393, (2006)

[5]

Davidson M.H., Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids, Am J Cardiol, 98, (2006)

[6]

Calder P.C., n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases, Am J Clin Nutr, 83, (2006)

[7]

Ma D.W., Seo J., Switzer K.C., Et al., n-3 PUFA and membrane microdomains: A new frontier in bioactive lipid research, J Nutr Biochem, 15, pp. 700-706, (2004)

[8]

Brenna J.T., Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man, Curr Opin Clin Nutr Metab Care, 5, pp. 127-132, (2002)

[9]

Kris-Etherton P.M., Harris W.S., Appel L.J., Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease, Circulation, 106, pp. 2747-2757, (2002)

[10]

Yokoyama M., Origasa H., Matsuzaki M., Et al., Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis, Lancet, 369, pp. 1090-1098, (2007)

← 1 2 3 →